newsfilter
← Latest News
ACCESS Newswire·

Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution

Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductionsReporting segment formerly known as Shared R&D renamed to Discovery & Preclinical